European Shorting
LLY has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
LLY has been removed from your Stock Email Alerts list.
Also See GuruFocus Insider Trade Screener:
| Insider | Position | Date | Buy/Sell | Shares | Shares Owned Following This | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Details |
|---|---|---|---|---|---|---|---|---|---|
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | 2013-05-15 | Sell | 5,000 | 76,597 | $56.15 | 280.8 | -1.8 | Link |
| Simmons Jeffrey N | SVP&Pres.,Elanco Animal Health | 2013-05-10 | Sell | 10,000 | 52,691 | $54.49 | 544.9 | 1.19 | Link |
| Mahony Susan | SVP & Pres., Lilly Oncology | 2013-04-29 | Sell | 3,500 | 53,111 | $56.33 | 197.2 | -2.11 | Link |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | 2013-04-15 | Sell | 5,000 | 76,295 | $57.1 | 285.5 | -3.43 | Link |
| Mahony Susan | SVP & Pres., Lilly Oncology | 2013-03-26 | Sell | 5,000 | 56,612 | $56 | 280 | -1.54 | Link |
| Lundberg Jan M | EVP,Science&Tech and Pres. LRL | 2013-03-12 | Sell | 19,000 | 100,253 | $55.38 | 1052.2 | -0.43 | Link |
| Ricks David A | SVP and Pres, Lilly Bio-Meds | 2013-02-08 | Sell | 3,000 | 29,259 | $53.91 | 161.7 | 2.28 | Link |
| Rice Derica W | EVP-Global Services and CFO (Click for the stocks that their CFOs have bought) | 2013-02-05 | Sell | 29,646 | 229,460 | $54.21 | 1607.1 | 1.72 | Link |
| Mahony Susan | SVP & Pres., Lilly Oncology | 2013-02-01 | Sell | 5,000 | 61,585 | $54.28 | 271.4 | 1.58 | Link |
| Tapiero Jacques | SVP&Pres., Emerging Markets | 2013-01-30 | Sell | 15,000 | 52,264 | $54.14 | 812.1 | 1.85 | Link |
| Mahony Susan | SVP & Pres., Lilly Oncology | 2012-10-24 | Sell | 10,000 | 28,141 | $50.45 | 504.5 | 9.3 | Link |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | 2012-08-01 | Sell | 5,000 | 31,311 | $44.16 | 220.8 | 24.86 | Link |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | 2012-07-02 | Sell | 5,000 | 36,311 | $43 | 215 | 28.23 | Link |
| Tapiero Jacques | SVP&Pres., Emerging Markets | 2012-06-14 | Sell | 2,125 | 39,594 | $41.6 | 88.4 | 32.55 | Link |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | 2012-06-01 | Sell | 5,000 | 41,313 | $40.6 | 203 | 35.81 | Link |
| HANISH ARNOLD C | Chief Accounting Officer | 2012-05-18 | Sell | 1,295 | 26,155 | $40.49 | 52.4 | 36.18 | Link |
| Tapiero Jacques | SVP&Pres., Emerging Markets | 2012-05-14 | Sell | 2,000 | 41,687 | $41.04 | 82.1 | 34.36 | Link |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | 2012-05-01 | Sell | 5,000 | 46,262 | $41.32 | 206.6 | 33.45 | Link |
| Tapiero Jacques | SVP&Pres., Emerging Markets | 2012-04-17 | Sell | 2,000 | 43,687 | $40 | 80 | 37.85 | Link |
| Conterno Enrique A | Sr. VP & Pres., Lilly Diabetes | 2012-04-02 | Sell | 5,000 | 51,263 | $40.3 | 201.5 | 36.82 | Link |
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.
Feedback
My Portfolios
Browse Gurus
Bookmark
Add to Portfolio
Get Email Alerts
RSS Update
Company Website
SEC Reports
RSS